152 related articles for article (PubMed ID: 29327476)
21. Phosphorylated EGFR at tyrosine 1173 correlates with poor prognosis in oral squamous cell carcinomas.
Monteiro L; Ricardo S; Delgado M; Garcez F; do Amaral B; Lopes C
Oral Dis; 2014 Mar; 20(2):178-85. PubMed ID: 23464360
[TBL] [Abstract][Full Text] [Related]
22. Expression of phosphotyrosine in squamous cell carcinoma of the oral mucosa. Preliminary study.
Maiorano E; Favia G
Boll Soc Ital Biol Sper; 1995; 71(5-6):157-62. PubMed ID: 8519490
[TBL] [Abstract][Full Text] [Related]
23. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
[TBL] [Abstract][Full Text] [Related]
24. EGF promotes PKM2 O-GlcNAcylation by stimulating O-GlcNAc transferase phosphorylation at Y976 and their subsequent association.
Wang Y; Shu H; Liu J; Jin X; Wang L; Qu Y; Xia M; Peng P; Feng Y; Wei M
J Biol Chem; 2022 Sep; 298(9):102340. PubMed ID: 35931120
[TBL] [Abstract][Full Text] [Related]
25. O-linked N-acetylglucosamine transferase (OGT) is overexpressed and promotes O-linked protein glycosylation in esophageal squamous cell carcinoma.
Qiao Z; Dang C; Zhou B; Li S; Zhang W; Jiang J; Zhang J; Kong R; Ma Y
J Biomed Res; 2012 Jul; 26(4):268-73. PubMed ID: 23554759
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of HIF-1α Affects Autophagy Mediated Glycosylation in Oral Squamous Cell Carcinoma Cells.
Li YN; Hu JA; Wang HM
Dis Markers; 2015; 2015():239479. PubMed ID: 26640316
[TBL] [Abstract][Full Text] [Related]
27. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation.
Chiang WF; Cheng TM; Chang CC; Pan SH; Changou CA; Chang TH; Lee KH; Wu SY; Chen YF; Chuang KH; Shieh DB; Chen YL; Tu CC; Tsui WL; Wu MH
Oncogene; 2018 Jan; 37(1):116-127. PubMed ID: 28892050
[TBL] [Abstract][Full Text] [Related]
28. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB.
Phoomak C; Vaeteewoottacharn K; Sawanyawisuth K; Seubwai W; Wongkham C; Silsirivanit A; Wongkham S
Sci Rep; 2016 Jun; 6():27853. PubMed ID: 27290989
[TBL] [Abstract][Full Text] [Related]
30. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
Goldberg H; Whiteside C; Fantus IG
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
[TBL] [Abstract][Full Text] [Related]
31. Tissue microarray analysis reveals the expression and prognostic significance of phosphorylated AktThr³⁰⁸ in oral squamous cell carcinoma.
Li Y; Wang J; Wang F; Wang H; Wang J; Zeng X; Liao G; Dan H; Chen Q
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Nov; 116(5):591-7. PubMed ID: 24018125
[TBL] [Abstract][Full Text] [Related]
32. O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells.
Kang ES; Han D; Park J; Kwak TK; Oh MA; Lee SA; Choi S; Park ZY; Kim Y; Lee JW
Exp Cell Res; 2008 Jul; 314(11-12):2238-48. PubMed ID: 18570920
[TBL] [Abstract][Full Text] [Related]
33. Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in mice.
Ida S; Morino K; Sekine O; Ohashi N; Kume S; Chano T; Iwasaki K; Harada N; Inagaki N; Ugi S; Maegawa H
Diabetologia; 2017 Sep; 60(9):1761-1769. PubMed ID: 28642969
[TBL] [Abstract][Full Text] [Related]
34. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
[TBL] [Abstract][Full Text] [Related]
35. New ELISA-based method for the detection of O-GlcNAc transferase activity in vitro.
Qi J; Wang R; Zeng Y; Yu W; Gu Y
Prep Biochem Biotechnol; 2017 Aug; 47(7):699-702. PubMed ID: 28296566
[TBL] [Abstract][Full Text] [Related]
36. MAPK/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy.
Zhang X; Ma L; Qi J; Shan H; Yu W; Gu Y
Mol Cell Biochem; 2015 Dec; 410(1-2):101-10. PubMed ID: 26318312
[TBL] [Abstract][Full Text] [Related]
37. O-GlcNAc cycling enzymes associate with the translational machinery and modify core ribosomal proteins.
Zeidan Q; Wang Z; De Maio A; Hart GW
Mol Biol Cell; 2010 Jun; 21(12):1922-36. PubMed ID: 20410138
[TBL] [Abstract][Full Text] [Related]
38. Quantitative regulation of nuclear pore complex proteins by O-GlcNAcylation.
Mizuguchi-Hata C; Ogawa Y; Oka M; Yoneda Y
Biochim Biophys Acta; 2013 Dec; 1833(12):2682-2689. PubMed ID: 23777819
[TBL] [Abstract][Full Text] [Related]
39. Hyperglycaemic conditions perturb mouse oocyte in vitro developmental competence via beta-O-linked glycosylation of heat shock protein 90.
Frank LA; Sutton-McDowall ML; Brown HM; Russell DL; Gilchrist RB; Thompson JG
Hum Reprod; 2014 Jun; 29(6):1292-303. PubMed ID: 24713123
[TBL] [Abstract][Full Text] [Related]
40. Functional analysis of recombinant human and Yarrowia lipolytica O-GlcNAc transferases expressed in Saccharomyces cerevisiae.
Oh HJ; Moon HY; Cheon SA; Hahn Y; Kang HA
J Microbiol; 2016 Oct; 54(10):667-74. PubMed ID: 27687229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]